Professor Mark Doherty
speaker
50 appearances
1 recordings
1 series
first heard Jul 2026
last heard 7 Jul
Professor Mark Doherty’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.
Appearances
Yes, for that year until she died.
I mean, you've heard from David some of the testimony as to how remarkable a woman Beatrice was, and all of it is true.
And David was also a remarkable support to her through that illness.
And for him and his team to have built this foundation in her memory and to have raised such a substantial amount of money over a very short period of time with clear goals as to how they want to see that money used and the kind of programs that they're interested in is really transformative, potentially for sarcoma care in Ireland.
So sarcomas are cancers of the soft tissue, of the connective tissue, of the bones of the body.
So they're much rarer than other cancers.
They account for about 1% of all cancers.
In Ireland, there's somewhere between 250 and 300 patients diagnosed each year with sarcoma of some type of the body.
Leomyosarcoma is one subtype, so about 20% of soft tissue sarcomas are leomyosarcomas.
And we built a specialist service at St.
Vincent's Hospital over the past kind of 10 or 12 years to centralise care to improve the service and the quality of care that we're offering for patients diagnosed with these rare cancers.
Internationally, we know from research that the best way to look after people with sarcoma is to have them in a centre where people are used to seeing us, where it's not a situation where there's one or two patients a year coming through the door, where it's every patient in the country is seen or a certain number are seen through.
So there are many people who get diagnosed with sarcoma who are cured of the illness.
But unfortunately, there are also a proportion of people who get diagnosed with what is often a very aggressive disease.
They may either be diagnosed with metastatic stage four cancer or they may go through initial treatment and in subsequent testing and follow up surveillance, we may find it reappear.
I suppose our overall figures would be about a 60% cure rate if you take all the patients, regardless of stage.
So often it can be relatively quiet or asymptomatic in the early stages of the disease.
Sometimes it can present as a painless lump or sometimes people will present with a pain or an ache somewhere, which may be treated early.
you know, with regular anti-inflammatories or treated as some sort of a musculoskeletal problem early on before it prompts referral for scanning.
And, you know, because of the rarity of the condition, number one, your average GP may only see one or two cases over their entire career of a new patient with sarcoma.
Showing 1–20 of 50 · page 1 of 3
Next →